Does PANTOPRAZOLE ANHYDROUS Cause Lung opacity? 21 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Lung opacity have been filed in association with PANTOPRAZOLE ANHYDROUS. This represents 1.5% of all adverse event reports for PANTOPRAZOLE ANHYDROUS.
21
Reports of Lung opacity with PANTOPRAZOLE ANHYDROUS
1.5%
of all PANTOPRAZOLE ANHYDROUS reports
1
Deaths
21
Hospitalizations
How Dangerous Is Lung opacity From PANTOPRAZOLE ANHYDROUS?
Of the 21 reports, 1 (4.8%) resulted in death, 21 (100.0%) required hospitalization, and 2 (9.5%) were considered life-threatening.
Is Lung opacity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE ANHYDROUS. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does PANTOPRAZOLE ANHYDROUS Cause?
Pain (633)
Rheumatoid arthritis (572)
Asthma (568)
Pyrexia (556)
Hypertension (555)
Rash (551)
Headache (550)
Fatigue (539)
Dyspnoea (509)
Hypersensitivity (498)
What Other Drugs Cause Lung opacity?
ALBUTEROL (296)
PREDNISONE (216)
TIOTROPIUM (196)
LANSOPRAZOLE (166)
IPRATROPIUM (157)
ACETAMINOPHEN (153)
MEPOLIZUMAB (149)
PANTOPRAZOLE (140)
BUDESONIDE\FORMOTEROL (139)
MONTELUKAST (137)
Which PANTOPRAZOLE ANHYDROUS Alternatives Have Lower Lung opacity Risk?
PANTOPRAZOLE ANHYDROUS vs PANTOTHENIC ACID
PANTOPRAZOLE ANHYDROUS vs PAPAVERINE
PANTOPRAZOLE ANHYDROUS vs PARACETAMOL
PANTOPRAZOLE ANHYDROUS vs PARATHYROID HORMONE
PANTOPRAZOLE ANHYDROUS vs PARECOXIB